I am an Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington, primarily working clinically at Harborview Medical Center. I work with the Recovery Clinic, Intake and Brief Intervention Services (IBIS), the Behavioral Health Integration Program (BHIP), and Addiction Consult Service.
I am fellowship-trained in Addiction Psychiatry, and board certified in both general and addiction psychiatry by the American Board of Psychiatry and Neurology. My passion is providing excellent, compassionate and comprehensive psychiatric care to my patients regardless of background or resources. I believe quality healthcare is a human right for all people and am excited help make that a reality as part of the Harborview system.
I am a clinical psychologist by training and an Assistant Professor at the University of Washington, Department of Psychiatry and Behavioral Sciences. I am also a Health Service Research Scientist at the Seattle-Denver HSR&D Center of Innovation for Veteran-Centered and Value-Driven Care at the VA Puget Sound Health Care System. My research program broadly focuses on bringing a more holistic approach to healthcare (i.e., mind, body, and spirit) and centers around two interconnected areas of investigation: 1) meaning-making and meaning in life among individuals with chronic pain and psychological distress (in particular, PTSD) and 2) developing and testing mind-body interventions that improve physical and emotional health and well-being. I am particularly interested in improving health for those in rural settings. My work has been supported by the National Center for Complementary and Integrative Health and the U.S. Department of Veterans Affairs.
Dr. Dahyeon Kang is an Assistant Professor at the University of Washington School of Medicine. She earned her doctoral degree from the University of Illinois at Urbana-Champaign, where her work focused on the etiology of alcohol and substance use disorders through multimodal research methods, including alcohol administration, neuroimaging, transdermal biosensors, and ecological momentary assessments. At the University of Washington’s Department of Psychiatry, Dr. Kang investigates how individual and social factors interact to influence alcohol and cannabis use behaviors.
Dr. Clausell earned his doctoral degree in Clinical-Community Psychology from the University of Illinois at Urbana-Champaign in 2011. Dr. Clausell’s graduate research focused on the legacy of childhood attachment relationships on relationship satisfaction of Gay and Lesbian Romantic Couples. Results of this research were published in the journal Developmental Psychology (2008). He completed his Predoctoral Clinical Internship at Veterans Affairs Palo Alto Health Care System and served as a Postdoctoral Research Fellow in Clinical Psychology in the Department of Psychiatry and Behavioral Sciences, Stanford Medicine. Dr. Clausell currently serves as the Director of the Couples & Family Program at Veterans Affairs Puget Sound Health Care System, Seattle Division. In addition, Dr. Clausell serves as Lead Trainer and Consultant in VA Central Office of Family Services for the dissemination program of Integrative Behavioral Couple Therapy lead by Developer & Distinguished Research Professor Dr. Andrew Christensen, at University of California, Los Angeles. Currently, Dr. Clausell serves as clinical trainer and supervisor for Seattle VA’s Clinical training programs, including Predoctoral, Postdoctoral, and the University of Washington Department of Psychiatry and Behavioral Sciences Resident Program where he currently serves at Rotation Supervisor for the VA Outpatient Couple and Family Therapy Rotation.
Christina Warner, MD (she/her) is the attending psychiatrist for the Early Psychosis Clinic and Partial Hospitalization Program at Seattle Children’s Hospital. She has clinical expertise in mood disorders, psychosis spectrum disorders, First Episode Psychosis, chronic suicidality, mood dysregulation, neurodiversity, and Dialectical Behavior Therapy.
Dr. Warner is a Washington native and graduate of the Seattle Public School system with a vested interest in expanding access to high quality mental health care in her community.
I am a clinical psychologist with specialized training in serious mental illness and inpatient psychiatric care. I earned my PhD from the University of Washington in 2023 after completing my pre-doctoral internship at the same institution, training in serious mental illness and inpatient care at Harborview Medical Center and psycho-oncology at Fred Hutch Cancer Center. My research focuses on developing novel technologies to support patients with serious mental illness, improve the provision of psychological interventions in the inpatient setting, and more efficiently and effectively train future generations of mental health clinicians. I also work as a psychologist on UW’s long-term civil commitment inpatient psychiatry program.
I am currently the Medical Director at the Garvey Institute Center for Neuromodulation and am providing leadership to help grow our portfolio in the area of Neuromodulation and Interventional Psychiatry. Before coming to the UW, I was the Muriel Harris Chair of Geriatric Psychiatry and Professor of Clinical Psychiatry at UCLA. While at UCLA, I held many administrative, clinical and teaching leadership positions including serving as Medical Director of Inpatient Geriatric Psychiatry, Chief of Staff of the UCLA Neuropsychiatric Hospital, Founding Faculty of the UCLA Neuromodulation Division, Medical Director of the ECT and Interventional Psychiatry Program, among others.
I recently became Editor-in-Chief of the Journal of ECT and Related Therapies, the official publication of the International Society of ECT and Neurostimulation. My research projects have included investigating various neuromodulation and interventional therapies and developing novel educational programs and curricula. I have an abiding interest in mentoring and helping faculty at the start of their careers and a commitment to fostering the advancement of women and underrepresented minority (URM) faculty in academic medicine.
My clinical and research interests center around behavioral and psychological symptoms that present in neurodegenerative diseases, especially dementias. Though dementia is well-known to affect one’s memory and cognition, over 90% of people with dementia develop new neuropsychiatric symptoms – including apathy, dysphoria. anxiety, aggression, agitation, disinhibition, hallucinations, and delusions. Despite the ubiquity of these symptoms, very little is known about how they develop in dementia. My research interests are in understanding more about the molecular and cellular mechanisms of neuropsychiatric symptoms in dementia beyond the well-studied changes associated with cognitive deficits.
Along with my research mentor Martin Darvas PhD (Department of Laboratory Medicine and Pathology), we employ numerous approaches to better understand these neuropsychiatric symptoms, including techniques involving transcriptomic analyses of human and mouse post-mortem tissue, development and implementation of biomarkers derived from human and animal model fluids (plasma, serum, cerebrospinal fluid), virally-mediated gene manipulations, animal modeling of cognitive and neuropsychiatric phenotypes, and basic cellular and molecular biology techniques.
Koriann Cox, Ph.D. graduated from Northeastern University and is licensed in the state of Washington. She completed a postdoctoral fellowship in co-occurring addiction and mental health and has a range of clinical experience with a variety of concerns including depression, anxiety, trauma, reproductive mental health, and substance and behavioral addictions. Dr. Cox’s strengths-focused approach emphasizes the mutual development of goals for therapy and ongoing collaboration between herself, the patient, and the care team. Dr. Cox uses a number of therapeutic modalities including but not limited to Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, and Cognitive Processing Therapy.
